Mepha Pharma

Innovative pharmaceutical developing, manufacturing and marketing branded and non-branded generic products.

Launch date

1949

Employees

Market cap

Net debt

Enterprise valuation

$615m (Public information from Feb 2010)

Aesch Canton of Basel-Landschaft (HQ)

Date	Investors	Amount	Round
Feb 2010	Cephalon	$615m Valuation: $615m	Acquisition
Total Funding		000k

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Mepha Pharma